pyrazolanthrone has been researched along with Glioma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auf, G; Bikfalvi, A; Delugin, M; Favereaux, A; Guérit, S; Jabouille, A; Maitre, M; Minchenko, D; Minchenko, O; Moenner, M; North, S; Pineau, R; Platonova, N; Seno, M; Vajkoczy, P | 1 |
| Chen, YC; Chen, YH; Lin, HY; Shen, SC; Wu, MS; Yang, LY | 1 |
| Hirose, Y; Kawase, T; Ohba, S; Sano, H | 1 |
| Dixit, D; Ghosh, S; Joseph, C; Koul, N; Sen, E; Sharma, V | 1 |
| Chen, YC; Cheng, MC; Chien, CC; Huang, GC; Lin, CT; Shen, SC; Wu, J; Yang, LY | 1 |
| Bhoopathi, P; Chetty, C; Gorantla, B; Kesanakurti, D; Lakka, SS; Rao, JS; Tsung, AJ | 1 |
| An, S; Choi, KS; Hwang, SG; Kang, SG; Kim, MJ; Kim, RK; Lee, SJ; Lim, EJ; Park, MJ; Suh, Y; Yoon, CH | 1 |
| Chen, GJ; Li, XS; Ran, JH; Tan, Y; Tang, WY; Yan, Y; Zhang, XD; Zhong, D | 1 |
| Meng, Q; Shi, Q; Wang, Y; Xu, X; Yu, R; Zhi, T; Zhou, X | 1 |
| Bian, XW; Chen, GL; Cui, YH; Duan, JJ; Gu, A; Li, TT; Qian, C; Shi, Y; Xin, YH; Xu, C; Yang, XJ; Yu, SC; Zhang, X | 1 |
| Ba, M; Chen, S; Lu, G; Ma, G; Wang, X; Yang, H | 1 |
| Hsu, SP; Huang, CN; Peng, CH; Wang, CJ | 1 |
12 other study(ies) available for pyrazolanthrone and Glioma
| Article | Year |
|---|---|
High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.
Topics: Animals; Anthracenes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Autocrine Communication; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cetuximab; Endoribonucleases; Epidermal Growth Factor; Epiregulin; ErbB Receptors; Gene Expression; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Protein Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2013 |
Reactive oxygen species-dependent nitric oxide production in reciprocal interactions of glioma and microglial cells.
Topics: Anthracenes; Butadienes; Cell Line, Tumor; Cell Survival; Chemokine CCL2; Coculture Techniques; Culture Media, Conditioned; Gene Expression Regulation, Neoplastic; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Microglia; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitriles; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2014 |
Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.
Topics: Activating Transcription Factor 2; Anthracenes; Antineoplastic Agents, Alkylating; beta-Galactosidase; Brain Neoplasms; Cell Death; Cell Division; Cell Line, Tumor; Cell Survival; Cellular Senescence; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; G2 Phase; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Temozolomide; Tumor Suppressor Protein p53 | 2009 |
HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
Topics: Acetylation; Anthracenes; Apoptosis; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; DNA Damage; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Glioma; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxylamines; JNK Mitogen-Activated Protein Kinases; Polymerase Chain Reaction; Quinolines; ras Proteins; Signal Transduction; Telomerase | 2010 |
Vitamin K3-2,3-epoxide induction of apoptosis with activation of ROS-dependent ERK and JNK protein phosphorylation in human glioma cells.
Topics: Acetylcysteine; Anthracenes; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Chromatin; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Vitamin K 3 | 2011 |
Suppression of MMP-2 attenuates TNF-α induced NF-κB activation and leads to JNK mediated cell death in glioma.
Topics: Animals; Anthracenes; Apoptosis; Blotting, Western; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Flow Cytometry; Glioma; Humans; Imidazoles; Immunohistochemistry; Immunoprecipitation; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Mice; NF-kappa B; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinase-3; Tumor Necrosis Factor-alpha | 2011 |
c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Topics: Anthracenes; Cell Line, Tumor; Cell Transformation, Neoplastic; Down-Regulation; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Neoplastic Stem Cells; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured | 2012 |
Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling.
Topics: Anthracenes; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Chromones; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Morpholines; Neoplasm Invasiveness; Phosphorylation; Proto-Oncogene Proteins c-akt; Syntenins | 2012 |
Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Protein Kinase Inhibitors; Signal Transduction | 2012 |
TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model.
Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Anthracenes; Cell Line, Tumor; Cell Movement; Chromones; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glioma; High-Throughput Screening Assays; Humans; Imidazoles; Macrophages; MAP Kinase Kinase 4; Morpholines; Neovascularization, Pathologic; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Signal Transduction; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays; Zebrafish | 2013 |
Short-term interleukin-1(beta) increases the release of secreted APP(alpha) via MEK1/2-dependent and JNK-dependent alpha-secretase cleavage in neuroglioma U251 cells.
Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Anthracenes; Aspartic Acid Endopeptidases; Cell Line, Tumor; Cell Survival; Endopeptidases; Enzyme Inhibitors; Flavonoids; Glioma; Humans; Interleukin-1; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein-Tyrosine Kinases; Solubility | 2005 |
Penta-acetyl geniposide-induced apoptosis involving transcription of NGF/p75 via MAPK-mediated AP-1 activation in C6 glioma cells.
Topics: Animals; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cell Line, Tumor; Electrophoretic Mobility Shift Assay; Flavonoids; Gardenia; Glioma; Glucosides; Imidazoles; Immunoblotting; Iridoid Glucosides; Iridoids; Keratolytic Agents; Masoprocol; Mitogen-Activated Protein Kinases; Molecular Structure; Nerve Growth Factor; NF-kappa B; Peptide Fragments; Pyridines; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation | 2007 |